# Kell antigen system

The Kell antigen system is a group of 38 red blood cell surface antigens encoded by the KEL gene, one of the clinically important human blood group systems after ABO and Rhesus. Its defining antigen, K (Kell, ISBT KEL1), is strongly immunogenic, and antibodies against Kell antigens cause hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN).<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup><sup> • </sup><sup>[2](https://blooddatabase.isbtweb.org/database)</sup>

| Key fact | Detail |
|---|---|
| ISBT designation | Symbol KEL, system number 006; 38 recognized antigens<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup><sup> • </sup><sup>[2](https://blooddatabase.isbtweb.org/database)</sup> |
| Discovery | 1946, by Coombs, Mourant, and Race; named for Mrs Kelleher, whose anti-K antibody caused HDFN in her newborn<sup>[3](https://www.ncbi.nlm.nih.gov/books/NBK2270/?report=reader)</sup><sup> • </sup><sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3595629/)</sup> |
| Main antigens | K (KEL1) and k (KEL2, Cellano) are antithetical and differ by a single amino acid, Thr193Met; the K−k+ phenotype occurs in 98% of Blacks and 91% of Caucasians<sup>[3](https://www.ncbi.nlm.nih.gov/books/NBK2270/?report=reader)</sup><sup> • </sup><sup>[5](https://www.genecards.org/card/KEL)</sup> |
| Gene | KEL on chromosome 7 (GRCh38 chr7:142,941,113–142,962,363), 19 exons, encoding a 732-amino-acid type II transmembrane glycoprotein (CD238)<sup>[2](https://blooddatabase.isbtweb.org/database)</sup><sup> • </sup><sup>[6](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)</sup> |
| Protein function | A zinc-dependent metalloproteinase with endothelin-3-converting enzyme activity, joined by a single disulfide bond (Kell Cys72–XK Cys347) to the XK membrane protein that carries the Kx antigen<sup>[6](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)</sup> |
| Clinical weight | Immunogenicity third after ABO and Rhesus D; anti-K is implicated in severe hemolytic transfusion reactions and HDFN<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> |
| Fetal expression | Kell antigens are detectable on fetal erythrocytes as early as 10 weeks gestation<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> |

## Discovery and history

The system was described in 1946, only weeks after the introduction of the antiglobulin (Coombs) test. Coombs, Mourant, and Race investigated cases of maternal-fetal incompatibility and found a mother's serum that reacted with her husband's red cells and with about 7 to 9 percent of random donor samples but fit no known system; Race named the antigen "Kell" after the mother's surname.<sup>[3](https://www.ncbi.nlm.nih.gov/books/NBK2270/?report=reader)</sup><sup> • </sup><sup>[7](https://www.ojp.gov/redirect-legacy/ncjrs/pdffiles1/pr/160880_unit_5.pdf)</sup><sup> • </sup><sup>[8](https://www.sciencedirect.com/topics/nursing-and-health-professions/blood-group-kell-system)</sup> The antithetical antigen k, called Cellano, was identified in 1949 as a high-frequency antigen, and the system remained a simple two-antigen system until 1957, when the antithetical Kp<sup>a</sup> and Kp<sup>b</sup> antigens and the K<sub>0</sub> (Kell-null) phenotype were reported.<sup>[8](https://www.sciencedirect.com/topics/nursing-and-health-professions/blood-group-kell-system)</sup> The Jsa and Jsb antigens, found in 1962 and 1963, were initially assigned to a separate "Sutter" system before being folded into Kell.<sup>[9](https://www.ojp.gov/pdffiles1/Digitization/94227NCJRS.pdf)</sup>

## Genetics and biochemistry

The KEL gene sits on chromosome 7 and encodes the Kell glycoprotein, a single-pass type II membrane protein of 732 amino acids, also known as CD238. Most Kell antigens arise from single nucleotide polymorphisms producing single amino acid substitutions; the K/k distinction is a Thr193Met change, and each of the other antigens similarly traces to a defined point mutation rather than a partial-expression pattern.<sup>[6](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)</sup><sup> • </sup><sup>[5](https://www.genecards.org/card/KEL)</sup><sup> • </sup><sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup>

Kell is a zinc-dependent metalloproteinase of the M13 family, related to neprilysin, and shows endothelin-3-converting enzyme activity. A single disulfide bond links it to the XK membrane protein, which carries the Kx antigen; absence of XK reduces Kell antigen expression on the red cell membrane.<sup>[6](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)</sup><sup> • </sup><sup>[5](https://www.genecards.org/card/KEL)</sup> This linkage ties the Kell system to the XK (ISBT 019) and Gerbich (ISBT 020) systems.<sup>[10](https://onlinelibrary.wiley.com/doi/full/10.1111/voxs.12593)</sup>

**Phenotype frequencies.** The k antigen is common in nearly all populations: the K−k+ phenotype is found in 98% of Blacks and 91% of Caucasians, so K-positive individuals are the minority, and anti-K serum reacts with roughly 7 to 9 percent of random donor samples.<sup>[3](https://www.ncbi.nlm.nih.gov/books/NBK2270/?report=reader)</sup><sup> • </sup><sup>[7](https://www.ojp.gov/redirect-legacy/ncjrs/pdffiles1/pr/160880_unit_5.pdf)</sup> The system also contains many high-prevalence antigens (such as Ku/KEL5, KEL11 through KEL14, KEL18, KEL19, and others) and low-prevalence antigens (such as Kp<sup>a</sup>/KEL3, Jsa/KEL6, Ul<sup>a</sup>/KEL10).<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> Rare K<sub>0</sub> red cells lack all Kell glycoprotein and every Kell system antigen.<sup>[11](https://www.sciencedirect.com/topics/medicine-and-dentistry/blood-group-kell-system)</sup>

## Antibodies and laboratory behavior

Anti-K antibodies are usually IgG, do not bind complement, and mostly react at 37 °C in the anti-human globulin (AHG) phase; IgM examples can react at room temperature, and naturally occurring anti-K occasionally appears, including transient examples in patients with [Escherichia coli](https://www.edgepedia.org/escherichia-coli) infections that disappear after recovery.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> Anti-K reactivity can be depressed with some low-ionic-strength solution reagents, so AHG-phase testing is required for reliable detection.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> Kell antigens resist treatment with proteolytic enzymes such as ficin, papain, and chymotrypsin, but all Kell antigens (together with the Cartwright Yt<sup>a</sup> antigen) are denatured by dithiothreitol (DTT) in the same concentration range, a property linked to disulfide bond integrity that laboratories exploit when distinguishing Kell from other antibody specificities.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup>

## Clinical significance

**Transfusion.** The K antigen is the system's clinically dominant member; one overview notes that of the more than 34 antigens, only K1 matters in routine practice.<sup>[11](https://www.sciencedirect.com/topics/medicine-and-dentistry/blood-group-kell-system)</sup> Anti-K has been implicated in severe hemolytic transfusion reactions and HDFN, and antibodies to high-prevalence Kell antigens such as k create the practical problem that few antigen-negative donor units exist, even though antibody formation against such antigens is rare because of their prevalence.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> People with the K<sub>0</sub> null phenotype can make anti-Ku (anti-KEL5) after transfusion, an antibody capable of causing mild to severe transfusion reactions, with at least one fatal case reported.<sup>[12](https://www.ncbi.nlm.nih.gov/books/NBK2270/pdf/Bookshelf_NBK2270.pdf)</sup><sup> • </sup><sup>[13](https://www.ncbi.nlm.nih.gov/sites/books/NBK609095/)</sup>

**Pregnancy.** Because Kell antigens appear on fetal red cells from about 10 weeks gestation, anti-Kell antibodies found in a pregnant person are followed closely to prevent and manage hemolytic disease of the fetus and newborn.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup> Non-invasive fetal Kell genotyping on circulating fetal DNA, using allelic discrimination of K1 and K2, has been developed as a testing approach.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup>

**McLeod syndrome.** Loss of the XK protein produces [McLeod syndrome](https://www.edgepedia.org/mcleod-syndrome), an X-linked recessive multisystem disorder with neurological, cardiovascular, and hematologic features, in which Kell antigen functions on red cells are lost; the Kell system is also associated in the literature with chronic granulomatous disease.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup>

## Nomenclature

The International Society of Blood Transfusion (ISBT) assigned the system symbol KEL and number 006; each antigen carries a six-digit number in which the first three digits identify the system, for example 006003 for Kp<sup>a</sup>, also written KEL3.<sup>[1](https://www.ncbi.nlm.nih.gov/books/NBK609095/)</sup><sup> • </sup><sup>[14](https://www.isbtweb.org/isbt-working-parties/rcibgt/blood-group-terminology.html)</sup> Phenotypes are written with a colon and comma-separated antigens, absent antigens marked with a minus sign (for example KEL:−1,2), and alleles in italic form such as KEL*02.<sup>[14](https://www.isbtweb.org/isbt-working-parties/rcibgt/blood-group-terminology.html)</sup> The ISBT allele table records eight antithetical antigen pairs within the system, including KEL1/KEL2, KEL3/KEL4/KEL21, and KEL6/KEL7.<sup>[6](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)</sup>

## References

1. [Kell Blood Group System, StatPearls, NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK609095/)
2. [ISBT Blood Group Database](https://blooddatabase.isbtweb.org/database)
3. [The Kell blood group, Blood Groups and Red Cell Antigens, NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK2270/?report=reader)
4. [A Brief History of Human Blood Groups, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC3595629/)
5. [KEL Gene, GeneCards](https://www.genecards.org/card/KEL)
6. [(ISBT 006) KEL blood group alleles v8.0, 30 September 2023](https://www.isbtweb.org/asset/E2E59D08-7BC6-4B66-887B105E7652C4E5/)
7. [Sourcebook in Forensic Serology, Immunology, and Biochemistry, Unit 5](https://www.ojp.gov/redirect-legacy/ncjrs/pdffiles1/pr/160880_unit_5.pdf)
8. [Blood Group Kell System: an overview, ScienceDirect Topics](https://www.sciencedirect.com/topics/nursing-and-health-professions/blood-group-kell-system)
9. [Ss, Kell, Duffy and Kidd Antigens, NCJRS](https://www.ojp.gov/pdffiles1/Digitization/94227NCJRS.pdf)
10. [Blood group systems (Smart, 2020), ISBT Science Series](https://onlinelibrary.wiley.com/doi/full/10.1111/voxs.12593)
11. [Blood Group Kell System: an overview, ScienceDirect Topics (medicine and dentistry)](https://www.sciencedirect.com/topics/medicine-and-dentistry/blood-group-kell-system)
12. [The Kell blood group (PDF), NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK2270/pdf/Bookshelf_NBK2270.pdf)
13. [Kell Blood Group System, StatPearls (alternate site)](https://www.ncbi.nlm.nih.gov/sites/books/NBK609095/)
14. [Blood Group Terminology, ISBT Working Party](https://www.isbtweb.org/isbt-working-parties/rcibgt/blood-group-terminology.html)

---
*Topic: Encyclopedia › Life and health › Human health and medicine › Human structure and function › Cardiovascular and lymphatic systems › Blood groups and transfusion medicine*

*Initially written Sep 17, 2026 · Reviewed: Oct 21, 2026 · Edited: Oct 15, 2026; Oct 21, 2026 · Last review: Oct 21, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license
